chr9-95478155-G-C

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_000264.5(PTCH1):ā€‹c.1247C>Gā€‹(p.Thr416Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000421 in 1,614,184 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T416I) has been classified as Likely benign.

Frequency

Genomes: š‘“ 0.00011 ( 0 hom., cov: 32)
Exomes š‘“: 0.000036 ( 0 hom. )

Consequence

PTCH1
NM_000264.5 missense

Scores

1
1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: 6.46
Variant links:
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), PTCH1. . Gene score misZ 1.6774 (greater than the threshold 3.09). Trascript score misZ 3.1343 (greater than threshold 3.09). GenCC has associacion of gene with holoprosencephaly 7, nevoid basal cell carcinoma syndrome, holoprosencephaly.
BP4
Computational evidence support a benign effect (MetaRNN=0.012770683).
BP6
Variant 9-95478155-G-C is Benign according to our data. Variant chr9-95478155-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 135109.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-95478155-G-C is described in Lovd as [Likely_benign]. Variant chr9-95478155-G-C is described in Lovd as [Pathogenic].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000105 (16/152296) while in subpopulation EAS AF= 0.00271 (14/5170). AF 95% confidence interval is 0.00164. There are 0 homozygotes in gnomad4. There are 9 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 16 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PTCH1NM_000264.5 linkuse as main transcriptc.1247C>G p.Thr416Ser missense_variant 9/24 ENST00000331920.11
PTCH1NM_001083603.3 linkuse as main transcriptc.1244C>G p.Thr415Ser missense_variant 9/24 ENST00000437951.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PTCH1ENST00000331920.11 linkuse as main transcriptc.1247C>G p.Thr416Ser missense_variant 9/245 NM_000264.5 A2Q13635-1
PTCH1ENST00000437951.6 linkuse as main transcriptc.1244C>G p.Thr415Ser missense_variant 9/245 NM_001083603.3 Q13635-2

Frequencies

GnomAD3 genomes
AF:
0.0000986
AC:
15
AN:
152178
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00270
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000195
AC:
49
AN:
251490
Hom.:
0
AF XY:
0.000191
AC XY:
26
AN XY:
135920
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00256
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000356
AC:
52
AN:
1461888
Hom.:
0
Cov.:
32
AF XY:
0.0000358
AC XY:
26
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00111
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.0000993
GnomAD4 genome
AF:
0.000105
AC:
16
AN:
152296
Hom.:
0
Cov.:
32
AF XY:
0.000121
AC XY:
9
AN XY:
74446
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00271
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.00000991
Hom.:
0
Bravo
AF:
0.000102
ExAC
AF:
0.000115
AC:
14
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Benign:2
Likely benign, criteria provided, single submittercurationSema4, Sema4Nov 25, 2021- -
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsApr 02, 2021This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not specified Benign:1Other:1
Benign, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoJul 16, 2021- -
not provided, no classification providedreference populationITMISep 19, 2013- -
PTCH1-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesDec 29, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Gorlin syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 25, 2024- -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxOct 29, 2019This variant is associated with the following publications: (PMID: 19362041, 18502968, 30093976, 24728327, 24668667) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
19
DANN
Benign
0.53
DEOGEN2
Benign
0.27
T;.;.;.;.;.;.;.
Eigen
Benign
-0.29
Eigen_PC
Benign
0.042
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.82
T;.;T;T;.;.;T;T
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.013
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.40
T
MutationAssessor
Benign
-0.55
N;.;.;.;.;.;.;.
MutationTaster
Benign
0.92
D;D;D;D;D;D;D
PrimateAI
Benign
0.48
T
PROVEAN
Benign
0.34
N;N;N;N;N;N;N;N
REVEL
Uncertain
0.39
Sift
Benign
1.0
T;T;T;T;T;T;T;T
Sift4G
Benign
1.0
T;T;T;T;T;T;T;.
Polyphen
0.0030
B;B;B;B;B;B;B;.
Vest4
0.31
MutPred
0.34
Gain of disorder (P = 0.048);.;.;.;.;.;.;.;
MVP
0.43
MPC
0.49
ClinPred
0.042
T
GERP RS
5.6
Varity_R
0.18
gMVP
0.098

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201174718; hg19: chr9-98240437; COSMIC: COSV59482056; COSMIC: COSV59482056; API